Diagnosis and Management of Autism Spectrum Disorder in the Era of Genomics
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Synopsis While the diagnosis of Autism Spectrum Disorder is based on behavioral signs and symptoms, the evaluation of a child with ASD has become increasingly focused on the identification of the genetic etiology of the disorder. Using chromosomal microarray and whole exome sequencing technology, more than 25% of children with ASD have an identifiable, causative genetic variant or syndrome, and this rate continues to increase with improved methods and widespread use of genetic testing. The identification of genetic variants has been accompanied by a concerted effort to define more homogeneous clinical syndromes that are informed by the underlying genetic etiology of a child’s ASD. In the future, such characterization will facilitate targeted treatments based on mechanisms of disease and common clinical features. In this review we begin with a clinical overview of ASD, highlighting the heterogeneity of the disorder. We then discuss the genetics of ASD and present updated guidelines on genetic testing. We then consider the insights gained from the identification of both single gene disorders and rare variants, with regard to clinical phenomenology and potential treatment targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations
O’Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., Levy, R., Ko, A., Lee, C., Smith, J. D., et al. (2012) · Nature · doi:10.1038/nature10989 · Cited by 2,165 · cited 2×
“However, recent advances in genetic methods have led to the identification of contributory mutations in up to 30% of children with ASD.(16,17) The first breakthrough technology was the chromosomal microarray analysis (CMA).”
BackgroundBaird, G., Simonoff, E., Pickles, A., Chandler, S., Loucas, T., Meldrum, D., & Charman, T. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69041-7 · Cited by 2,104
De novo mutations revealed by whole-exome sequencing are strongly associated with autism
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., et al. (2012) · Nature · doi:10.1038/nature10945 · Cited by 2,084 · cited 1×
“More recently, wholeexome and whole-genome sequencing technology has facilitated investigations at the level of the single base pair, allowing for analysis of single gene defects and for the identification of partial loss of gene function.(16,17,20,21) Most large-scale exome-sequencing”
BackgroundEpidemiology of Pervasive Developmental Disorders
Fombonne, E. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819e7203 · Cited by 1,971 · cited 1×
“Like most neurodevelopmental disorders, ASD has a strong male predominance.(4) There are 2 primary reasons for this uneven gender distribution.”
BackgroundPatterns and rates of exonic de novo mutations in autism spectrum disorders
Neale, B. M., Kou, Y., Liu, L., Ma’ayan, A., Samocha, K. E., Sabo, A., Lin, C.-F., Stevens, C., Wang, L.-S., Makarov, V., et al. (2012) · Nature · doi:10.1038/nature11011 · Cited by 1,734 · cited 2×
“However, recent advances in genetic methods have led to the identification of contributory mutations in up to 30% of children with ASD.(16,17) The first breakthrough technology was the chromosomal microarray analysis (CMA).”
BackgroundDe Novo Gene Disruptions in Children on the Autistic Spectrum
Iossifov, I., Ronemus, M., Levy, D., Wang, Z., Hakker, I., Rosenbaum, J., Yamrom, B., Lee, Y.-H., Narzisi, G., Leotta, A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.04.009 · Cited by 1,446
Recurrence Risk for Autism Spectrum Disorders: A Baby Siblings Research Consortium Study
Ozonoff, S., Young, G. S., Carter, A., Messinger, D., Yirmiya, N., Zwaigenbaum, L., Bryson, S., Carver, L. J., Constantino, J. N., Dobkins, K., et al. (2011) · Pediatrics · doi:10.1542/peds.2010-2825 · Cited by 1,429
Sandin, S., Lichtenstein, P., Kuja-Halkola, R., Larsson, H., Hultman, C. M., & Reichenberg, A. (2014) · JAMA · doi:10.1001/jama.2014.4144 · Cited by 1,073 · cited 1×
“These heritability estimates can be useful when counseling patients about family planning based on family history of ASD.(14) Considerable research efforts have been”
BackgroundConvergence of genes and cellular pathways dysregulated in autism spectrum disorders
Pinto, D., Delaby, E., Merico, D., Barbosa, M., Merikangas, A., Klei, L., Thiruvahindrapuram, B., Xu, X., Ziman, R., Wang, Z., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.03.018 · Cited by 969
Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis
Ehninger, D., Han, S., Shilyansky, C., Zhou, Y., Li, W., Kwiatkowski, D. J., Ramesh, V., & Silva, A. J. (2008) · Nature Medicine · doi:10.1038/nm1788 · Cited by 882 · cited 1×
“These studies have revealed that mTOR inhibitors can reverse the cognitive and social impairments found in adult mouse models after surprisingly short courses of treatment.(36,37) In turn, these promising findings have inspired the investigation of mTOR inhibitors, such as rapamycin, in patients with TSC.”
BackgroundCNVs: Harbingers of a Rare Variant Revolution in Psychiatric Genetics
Malhotra, D., & Sebat, J. (2012) · Cell · doi:10.1016/j.cell.2012.02.039 · Cited by 854
Dworzynski, K., Ronald, A., Bolton, P., & Happé, F. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.05.018 · Cited by 633 · cited 1×
“Second, specific genetic factors may protect girls from developing ASD (“female protective effect”).(8,9) Support for this theory comes from studies demonstrating a greater ASD-related genetic load in female individuals with ASD compared with male individuals with ASD, and in clinically unaffected female relatives com…”
BackgroundSchaefer, G. B., & Mendelsohn, N. J. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.32 · Cited by 537 · cited 1×
“1).(25) After a comprehensive 3-generation family history, ACMG recommends a CMA for all children.”
BackgroundSensitivity and specificity of proposed DSM-5 diagnostic criteria for autism spectrum disorder
McPartland, J. C., Reichow, B., & Volkmar, F. R. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.01.007 · Cited by 476 · cited 1×
“Some studies demonstrate very high consistency, whereas others demonstrate more discrepancy, particularly in those previously given a PDDNOS diagnosis.(2,3) Of note, from a clinical perspective, a child diagnosed through DSM-IV need not be reevaluated for diagnostic purposes simply because of the changes in DSM-5.”
ResultUsing Whole-Exome Sequencing to Identify Inherited Causes of Autism
Yu, T. W., Chahrour, M. H., Coulter, M. E., Jiralerspong, S., Okamura-Ikeda, K., Ataman, B., Schmitz-Abe, K., Harmin, D. A., Adli, M., Malik, A. N., et al. (2013) · Neuron · doi:10.1016/j.neuron.2012.11.002 · Cited by 442
The role of epilepsy and epileptiform EEGs in autism spectrum disorders
Spence, S. J., & Schneider, M. T. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819e7168 · Cited by 418
The role of de novo mutations in the genetics of autism spectrum disorders
Ronemus, M., Iossifov, I., Levy, D., & Wigler, M. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3585 · Cited by 390
Behavioral treatments in autism spectrum disorder: what do we know?
Vismara, L. A., & Rogers, S. J. (2010) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.121208.131151 · Cited by 376 · cited 1×
“Under the umbrella term of “ABA” or applied behavioral analysis, falls several effective and distinct methods.(33) The traditional ABA program, based on the work of Lovaas and colleagues,(34) is intensive and individualized, with the use of discrete trials to teach simple skills that then can build to more complex ski…”
BackgroundAutism Symptoms and Internalizing Psychopathology in Girls and Boys with Autism Spectrum Disorders
Solomon, M., Miller, M., Taylor, S. L., Hinshaw, S. P., & Carter, C. S. (2012) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-011-1215-z · Cited by 326
Clinical characteristics of children with autism spectrum disorder and co-occurring epilepsy.
Viscidi, E. W., Triche, E. W., Pescosolido, M. F., McLean, R. L., Joseph, R. M., Spence, S. J., & Morrow, E. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067797 · Cited by 235 · cited 1×
“The largest cross-sectional study of almost 6000 children with ASD and epilepsy found that epilepsy in ASD was associated with lower cognitive, adaptive, and language ability, as well as greater autism severity, with peak prevalence of epilepsy occurring at age 10.(28)”
BackgroundSex differences in repetitive stereotyped behaviors in autism: Implications for genetic liability
Szatmari, P., Liu, X., Goldberg, J., Zwaigenbaum, L., Paterson, A. D., Woodbury‐Smith, M., Georgiades, S., Duku, E., & Thompson, A. (2012) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31238 · Cited by 187
Urraca, N., Cleary, J., Brewer, V., Pivnick, E. K., McVicar, K., Thibert, R. L., Schanen, N. C., Esmer, C., Lamport, D., & Reiter, L. T. (2013) · Autism Research · doi:10.1002/aur.1284 · Cited by 164
Hattier, M. A., Matson, J. L., Tureck, K., & Horovitz, M. (2011) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2011.07.028 · Cited by 104
Brief Report: Comparability of DSM-IV and DSM-5 ASD Research Samples
Mazefsky, C. A., McPartland, J. C., Gastgeb, H. Z., & Minshew, N. J. (2013) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-012-1665-y · Cited by 88 · cited 1×
“Some studies demonstrate very high consistency, whereas others demonstrate more discrepancy, particularly in those previously given a PDDNOS diagnosis.(2,3) Of note, from a clinical perspective, a child diagnosed through DSM-IV need not be reevaluated for diagnostic purposes simply because of the changes in DSM-5.”
ResultAdvances in the early detection of autism
Zwaigenbaum, L. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283372430 · Cited by 64 · cited 1×
“Earlier in infancy, prebehavioral biomarkers of risk include differences in resting state electroencephalogram (EEG) patterns and face processing.(15) These studies have been instrumental in reinforcing that atypical patterns of both brain development and behavior can be quantified early in the developmental period, b…”
Background
Cited by
Tammimies, K., Marshall, C. R., Walker, S., Kaur, G., Thiruvahindrapuram, B., Lionel, A. C., Yuen, R. K. C., Uddin, M., Roberts, W., Weksberg, R., et al. (2015) · JAMA · doi:10.1001/jama.2015.10078 · Cited by 419
State of the field: Differentiating intellectual disability from autism spectrum disorder
Thurm, A., Farmer, C., Salzman, E., Lord, C., & Bishop, S. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00526 · Cited by 267
Common and unique multimodal covarying patterns in autism spectrum disorder subtypes
Qi, S., Morris, R., Turner, J. A., Fu, Z., Jiang, R., Deramus, T. P., Zhi, D., Calhoun, V. D., & Sui, J. (2020) · Molecular Autism · doi:10.1186/s13229-020-00397-4 · Cited by 58
Metadata
- Authors
- Baker, E., & Jeste, S. S.
- Venue
- Pediatric Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 62
- Issue
- 3
- Pages
- 607-618
- ISSN
- 0031-3955 (ISSN-L)
- OpenAlex
- W2136373302
- Cited by
- 39
- References
- 25
- FWCI
- 3.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.